Site Search
410 result(s) found for “ adaptive therapy”
-
The History of CAR T-Cell Therapy and Dr. Patrick Hwu
Explore the history and development of CAR T-cell therapy, highlighting key scientists, discoveries, and immunotherapy advances, including Dr....
-
Tumor Infiltrating Lymphocyte Therapy (TIL) has Shown Promise in Melanoma Treatment
Moffitt is at the forefront of Tumor infiltrating lymphocyte therapy (TIL), a cellular therapy to treat melanoma and other solid tumors.
-
Moffitt Researchers Develop Mathematical Measures to Better Personalize Therapy for Prostate Cancer
New approach using routine PSA information may help identify patients most likely to benefit from treatment breaks
-
Early Antiviral Therapy Prevents Severe COVID-19 Illness in High-Risk Patients
Study shows remdesivir can reduce risk of hospitalization or death by 87%
-
Inflammation from Androgen Deprivation Therapy May Cause Fatigue in Prostate Cancer Patients
Moffitt Cancer Center study suggests elevation in inflammation marker IL-6 linked to higher levels of fatigue
-
Mathematical Modeling Offers New Way to Understand Variable Responses to Targeted Therapy
Differences among tumor cells and the surrounding environment impact a tumor’s response to therapy
-
Next Generation of TIL Therapy Being Developed for Head and Neck Cancers
Standard of care fails 80% of patients with advanced squamous cell carcinoma
-
Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer
Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy
-
18MA033 TILs: TILs modified with CAR constructs result in CAR-TILs for Cancer Therapy
TILs modified with CAR constructs result in CARTILs for Cancer Therapy Download PDFTo date, chimeric antigen receptor T-cell (CAR-T) therapy has had...
-
New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press
Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data